Nanomedicine News

RSS

"Cocktail" of Different Nanometer-Sized Particles Locate, Adhere to and Kill Cancerous Tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors...

4 Jan 2010

Winner Medical Group Opens Three PurCotton Pilot Chain Stores

Winner Medical Group Inc. (NYSE Amex: WWIN; "Winner Medical", or the "Company"), a leading manufacturer and exporter of medical, wound care and home care products in China, today announced that it has...

4 Jan 2010

Leading Biomedical Engineer to Conduct a Stimulating and Informative Presentation at MD+M West

Zeus, Inc., a leader in polymer extrusions and material science, announces that Dr. Bruce Anneaux, Corporate Manager, Research + Development for Zeus, will present at MD+M West in Anaheim, California on Tuesday, February 9, 2010.

4 Jan 2010

Single Atom Controls How Bacteria Walk

Bacteria can swim, propelling themselves through fluids using a whip-like extension called a flaggella. They can also walk, strolling along solid surfaces using little fibrous legs called pili. It is this motility that enable some pathogenic bacteria to establish the infections - such as meningitis - that cause their human hosts to get sick or even die.

4 Jan 2010

Biodegradable Nanosized Particles to Deliver Sustained-Release Medication Cargo

Johns Hopkins University researchers have created biodegradable nanosized particles that can easily slip through the body's sticky and viscous mucus secretions to deliver a sustained-release medication cargo.

4 Jan 2010

Faster Sequencing of DNA with Carbon Nanotube

Faster sequencing of DNA holds enormous potential for biology and medicine, particularly for personalized diagnosis and customized treatment based on each individual's genomic makeup.

31 Dec 2009

Luna Innovations Incorporated Acquires Certain Intellectual Property Assets of Tego Biosciences

Luna Innovations Incorporated (NASDAQ: LUNA) has acquired certain intellectual property assets of Tego Biosciences, its main competitor in developing medicines based on carbon nanomaterials. Tego Biosciences, Inc. is a wholly owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR).

29 Dec 2009